OBJECTIVE: This study evaluated the effects of cognitive remediation for improving cognitive performance, symptoms, and psychosocial functioning in schizophrenia. METHOD: A meta-analysis was conducted of 26 randomized, controlled trials of cognitive remediation in schizophrenia including 1,151 patients. RESULTS: Cognitive remediation was associated with significant improvements across all three outcomes, with a medium effect size for cognitive performance (0.41), a slightly lower effect size for psychosocial functioning (0.36), and a small effect size for symptoms (0.28). The effects of cognitive remediation on psychosocial functioning were significantly stronger in studies that provided adjunctive psychiatric rehabilitation than in those that provided cognitive remediation alone. CONCLUSIONS: Cognitive remediation produces moderate improvements in cognitive performance and, when combined with psychiatric rehabilitation, also improves functional outcomes.
OBJECTIVE: This study evaluated the effects of cognitive remediation for improving cognitive performance, symptoms, and psychosocial functioning in schizophrenia. METHOD: A meta-analysis was conducted of 26 randomized, controlled trials of cognitive remediation in schizophrenia including 1,151 patients. RESULTS: Cognitive remediation was associated with significant improvements across all three outcomes, with a medium effect size for cognitive performance (0.41), a slightly lower effect size for psychosocial functioning (0.36), and a small effect size for symptoms (0.28). The effects of cognitive remediation on psychosocial functioning were significantly stronger in studies that provided adjunctive psychiatric rehabilitation than in those that provided cognitive remediation alone. CONCLUSIONS: Cognitive remediation produces moderate improvements in cognitive performance and, when combined with psychiatric rehabilitation, also improves functional outcomes.
Authors: S Pilling; P Bebbington; E Kuipers; P Garety; J Geddes; B Martindale; G Orbach; C Morgan Journal: Psychol Med Date: 2002-07 Impact factor: 7.723
Authors: P D Harvey; M R Serper; L White; M J Parrella; S R McGurk; P J Moriarty; C Bowie; N Vadhan; J Friedman; K L Davis Journal: Compr Psychiatry Date: 2001 Jul-Aug Impact factor: 3.735
Authors: Til Wykes; Clare Reeder; Clare Williams; Julia Corner; Christopher Rice; Brian Everitt Journal: Schizophr Res Date: 2003-06-01 Impact factor: 4.939
Authors: Triptish Bhatia; Akhilesh Agarwal; Gyandeepak Shah; Joel Wood; Jan Richard; Raquel E Gur; Ruben C Gur; Vishwajit L Nimgaonkar; Sati Mazumdar; Smita N Deshpande Journal: Acta Neuropsychiatr Date: 2011-08-10 Impact factor: 3.403
Authors: J Cobb Scott; Georg E Matt; Kristen M Wrocklage; Cassandra Crnich; Jessica Jordan; Steven M Southwick; John H Krystal; Brian C Schweinsburg Journal: Psychol Bull Date: 2014-11-03 Impact factor: 17.737
Authors: Elena A Spieker; Robert S Astur; Jeffrey T West; Jacqueline A Griego; Laura M Rowland Journal: Schizophr Res Date: 2011-12-09 Impact factor: 4.939
Authors: W Wolfgang Fleischhacker; Celso Arango; Paul Arteel; Thomas R E Barnes; William Carpenter; Ken Duckworth; Silvana Galderisi; Lisa Halpern; Martin Knapp; Stephen R Marder; Mary Moller; Norman Sartorius; Peter Woodruff Journal: Schizophr Bull Date: 2014-04 Impact factor: 9.306